Advertisement
Advertisement
BLLN
B
BillionToOne, Inc. Class A Common Stock
92.96
USDSponsored
+0.06
+0.06%
May 08, 16:00 UTC -4
Closed
After-Market
92.13
-0.83
-0.90%
BLLN Earnings Reports
Positive Surprise Ratio
BLLN beat 2 of 3 last estimates.
67%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
BillionToOne, Inc. Class A Common Stock earnings per share and revenue
On May 06, 2026, BLLN reported earnings of 0.34 USD per share (EPS) for Q1 26, beating the estimate of 0.04 USD, resulting in a 598.15% surprise. Revenue reached 108.39 million, compared to an expected 98.82 million, with a 9.68% difference. The market reacted with a +14.13% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were BillionToOne, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, BillionToOne, Inc. Class A Common Stock reported EPS of $0.34, beating estimates by 598.15%, and revenue of $108.39M, 9.68% above expectations.
How did the market react to BillionToOne, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 14.13%, changed from $81.40 before the earnings release to $92.90 the day after.
When is BillionToOne, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for BillionToOne, Inc. Class A Common Stock's next earnings report?
Based on --
analysts, BillionToOne, Inc. Class A Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement